212 related articles for article (PubMed ID: 17101065)
21. Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy.
Annaberdyev S; Gibbons J; Hardacre JM
World J Surg Oncol; 2009 Mar; 7():30. PubMed ID: 19291285
[TBL] [Abstract][Full Text] [Related]
22. The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction.
Staiger WI; Ronellenfitsch U; Kaehler G; Schildhaus HU; Dimitrakopoulou-Strauss A; Schwarzbach MH; Hohenberger P
World J Surg Oncol; 2008 Apr; 6():37. PubMed ID: 18394167
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors.
Eisenberg BL; Trent JC
Int J Cancer; 2011 Dec; 129(11):2533-42. PubMed ID: 21671474
[TBL] [Abstract][Full Text] [Related]
24. Management of gastrointestinal stromal tumors: looking beyond the knife. An update on the role of adjuvant and neoadjuvant imatinib therapy.
Pandey R; Kochar R
J Gastrointest Cancer; 2012 Dec; 43(4):547-52. PubMed ID: 22847491
[TBL] [Abstract][Full Text] [Related]
25. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.
Blay JY; Bonvalot S; Casali P; Choi H; Debiec-Richter M; Dei Tos AP; Emile JF; Gronchi A; Hogendoorn PC; Joensuu H; Le Cesne A; McClure J; Maurel J; Nupponen N; Ray-Coquard I; Reichardt P; Sciot R; Stroobants S; van Glabbeke M; van Oosterom A; Demetri GD;
Ann Oncol; 2005 Apr; 16(4):566-78. PubMed ID: 15781488
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant imatinib in a locally advanced gastrointestinal stromal tumour (GIST) of the rectum: a rare case of two GISTs within a family without a familial GIST syndrome.
Mandalà M; Pezzica E; Tamborini E; Guerra U; Lagonigro SM; Forloni B; Barni S
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):711-3. PubMed ID: 17625442
[TBL] [Abstract][Full Text] [Related]
27. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib.
Bauer S; Hartmann JT; de Wit M; Lang H; Grabellus F; Antoch G; Niebel W; Erhard J; Ebeling P; Zeth M; Taeger G; Seeber S; Flasshove M; Schütte J
Int J Cancer; 2005 Nov; 117(2):316-25. PubMed ID: 15900603
[TBL] [Abstract][Full Text] [Related]
28. Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.
Wilson J; Connock M; Song F; Yao G; Fry-Smith A; Raftery J; Peake D
Health Technol Assess; 2005 Jul; 9(25):1-142. PubMed ID: 15985189
[TBL] [Abstract][Full Text] [Related]
29. Imatinib: a review of its use in the management of gastrointestinal stromal tumours.
Siddiqui MA; Scott LJ
Drugs; 2007; 67(5):805-20. PubMed ID: 17385949
[TBL] [Abstract][Full Text] [Related]
30. [Clinical analysis of 156 patients with gastrointestinal stromal tumors receiving imatinib therapy].
Zhang L; Cai M; Deng J; Wang X; Wang B; Liu N; Pan Y; Zhang R; Cui Q; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):331-4. PubMed ID: 24760639
[TBL] [Abstract][Full Text] [Related]
31. Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib.
Ruka W; Rutkowski P; Szawłowski A; Nowecki Z; Debiec-Rychter M; Grzesiakowska U; Dziewirski W; Siedlecki JA; Michej W
Eur J Surg Oncol; 2009 Jan; 35(1):87-91. PubMed ID: 18289826
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant therapy with imatinib mesylate for locally advanced GI stromal tumor.
Shah JN; Sun W; Seethala RR; Livolsi VA; Fry RD; Ginsberg GG
Gastrointest Endosc; 2005 Apr; 61(4):625-7. PubMed ID: 15812427
[No Abstract] [Full Text] [Related]
33. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
34. [Evidence-based treatment of gastrointestinal stromal tumor (GIST) with tyrosine kinase inhibitors-imatinib and sunitinib].
Nishida T; Omori T; Ueshima S
Gan To Kagaku Ryoho; 2011 May; 38(5):733-7. PubMed ID: 21566432
[TBL] [Abstract][Full Text] [Related]
35. Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate.
Goh BK; Chow PK; Chuah KL; Yap WM; Wong WK
Eur J Surg Oncol; 2006 Nov; 32(9):961-3. PubMed ID: 16842963
[TBL] [Abstract][Full Text] [Related]
36. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
[TBL] [Abstract][Full Text] [Related]
37. C-kit, GIST, and imatinib.
Siehl J; Thiel E
Recent Results Cancer Res; 2007; 176():145-51. PubMed ID: 17607922
[TBL] [Abstract][Full Text] [Related]
38. [Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors].
Heger U; Weitz J; Lordick F
Chirurg; 2008 Jul; 79(7):630-7. PubMed ID: 18548219
[TBL] [Abstract][Full Text] [Related]
39. [Chinese consensus in diagnosis and treatment of gastrointestinal stromal tumor].
Chinese Diagnosis and Treatment Experts Group for Gastrointestinal Stromal Tumors
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):697-702. PubMed ID: 20078976
[No Abstract] [Full Text] [Related]
40. Perioperative treatment of gastrointestinal stromal tumors.
Fernandes Gdos S; Blanke CD; Freitas D; Guedes R; Hoff PM
Oncology (Williston Park); 2009 Jan; 23(1):54-61. PubMed ID: 19283922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
